Cyromazine and its associated end-use products : consultation document. : H113-27/2020-2E-PDF

"This document presents the proposed regulatory decision for the re-evaluation of cyromazine including the proposed risk mitigation measures to further protect human health and the environment, as well as the science evaluation on which the proposed decision was based. All products containing cyromazine registered in Canada are subject to this proposed re-evaluation decision. This document is subject to a 90-day public consultation period, during which the public including the pesticide manufacturers and stakeholders may submit written comments and additional information to the PMRA. The final re-evaluation decision will be published taking into consideration the comments and information received"--page 1.

Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.884461&sl=1

• Format MARC XML
• Format MARC HTML

Demander des formats alternatifs